Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics

Vassiliki Kotoula, Elpida Charalambous, Bart Biesmans et al. · 2009

Read Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics by Vassiliki Kotoula, Elpida Charalambous, Bart Biesmans et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007746.txt.

Description

Vassiliki Kotoula and co-authors published a study in PLOS ONE in 2009. It tackles a practical problem in cancer diagnosis. Doctors test tumor tissue for mutations in a gene called KRAS. The result can predict whether a treatment will work.

Routine tumor samples are fixed in formalin and embedded in paraffin, which damages DNA. The team assessed KRAS mutations on such real-world material. They used a sensitive real-time PCR method in a live diagnostic setting. Showing the test works on standard hospital samples is a key step. It brings mutation-guided treatment closer to everyday oncology practice.

Catalog record

CREATORVassiliki Kotoula, Elpida Charalambous, Bart Biesmans et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007746

Browse the full library · About the Tower of Babel